Contribution By Saipriya Iyer
Spring Bank Pharmaceuticals, a renowned US-based biopharmaceutical firm engaged in the development and discovery of new class of medicines from its small molecule nucleic acid hybrid (SMNH) chemical platform, reportedly announced that it has started
The collaboration aims at providing enhanced levels of safety in head protection
ARK helmet provides 38% reduction in strain to the brain in the event of an impact
U.S. based testing laboratories company- National Technical Systems, Inc. h
The fierce competition amidst various food companies has left them to come up with innovative and competitive strategies to attract a massive range of customers to their food platform. In the light of this, Taco Bell, following the grand success of P
The collaboration has been forged to expand the ‘Digital Partner Program’, of which Microsoft and PTC are already part of.
Digital transformation of operations across companies has raised the requirement to develop an ecosystem of partners t
Patient assistance programs, government initiatives towards cancer awareness, prevalence of cancer, and the subsequent rise in R&D initiatives and cancer-related clinical trials are the primary factors pushing advancements in the field of cancer
The pharmaceutical company, Esperion Therapeutics, reportedly announced its four Phase 3 studies of the bempedoic acid at the American Heart Association Scientific Sessions in Philadelphia. The acid, as per credible sources, is being manufactured as
Agile Therapeutics, Inc., a New Jersey based pharmaceutical company that is focused at women’s healthcare, has reportedly announced that the United States Food and Drug Administration has extended its PDUFA (Prescription Drug User Fee Act) target d
Mars, Inc. has recently revealed plans to launch a new vegan alternative to its famous Galaxy bar in the UK, making it the first mainstream confectionery brand to provide consumers with a plant-based option to milk chocolate.
Reportedly, the Vegan
Growing prevalence of cardiovascular diseases across the globe have increased the risk of reperfusion injury in patients. While strong R&D activities from prominent players in the medical market are propelling the cardiovascular therapy market, v